Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial-Reference-Cited by-同舟云学术

Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial

Published:2019-04 Issue:4 Volume:6 Page:e221-e229
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Krupitsky Evgeny,Blokhina Elena,Zvartau Edwin,Verbitskaya Elena,Lioznov Dmitri,Yaroslavtseva Tatiana,Palatkin Vladimir,Vetrova Marina,Bushara Natalia,Burakov Andrei,Masalov Dmitri,Mamontova Olga,Langleben Daniel,Poole Sabrina,Gross Robert,Woody George

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference30 articles.

1. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST);Spire;Int J Drug Policy,2007

2. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study;Altice;J Acquir Immune Defic Syndr,2011

3. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy;Palepu;Drug Alcohol Depend,2006

5. Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine;Marcus;Drug Alcohol Depend,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opioids and Immunosuppression: Clinical Evidence, Mechanisms of Action, and Potential Therapies;Palliative Medicine Reports;2024-02-01

2. Disorders due to Substance Use: Opioids and Opioid Addiction;Tasman’s Psychiatry;2024

3. Rapid access to antiretroviral therapy, receipt of naltrexone, and strengths-based case management versus standard of care for HIV viral load suppression in people with HIV who inject drugs in Russia (LINC-II): an open-label, randomised controlled trial;The Lancet HIV;2023-09

4. Disorders Due to Substance Use: Opioids and Opioid Addiction;Tasman’s Psychiatry;2023

5. Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-09